CELECOXIB DEMONSTRATES LOWER RATES OF HEPATIC TOXICITY BUT SIMILAR EFFICACY TO DICLOFENAC IN THE TREATMENT OF OSTEOARTHRITIS IN LATIN AMERICAN PATIENTS: SUCCESS I TRIAL

MLA

John G. Fort, et al. “Celecoxib Demonstrates Lower Rates of Hepatic Toxicity but Similar Efficacy to Diclofenac in the Treatment of Osteoarthritis in Latin American Patients: Success I Trial.” JCR: Journal of Clinical Rheumatology, vol. 12, Aug. 2006, p. S27. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ecf710ca4ac4551c05b37fa2e794a738&authtype=sso&custid=ns315887.

APA

John G. Fort, Lilia Andrade-Ortega, L Niculescu, G Triadafilopoulos, Roger A. Levy, W Dodge, & Gurkirpal Singh. (2006). Celecoxib Demonstrates Lower Rates of Hepatic Toxicity but Similar Efficacy to Diclofenac in the Treatment of Osteoarthritis in Latin American Patients: Success I Trial. JCR: Journal of Clinical Rheumatology, 12, S27.

Chicago

John G. Fort, Lilia Andrade-Ortega, L Niculescu, G Triadafilopoulos, Roger A. Levy, W Dodge, and Gurkirpal Singh. 2006. “Celecoxib Demonstrates Lower Rates of Hepatic Toxicity but Similar Efficacy to Diclofenac in the Treatment of Osteoarthritis in Latin American Patients: Success I Trial.” JCR: Journal of Clinical Rheumatology 12 (August): S27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ecf710ca4ac4551c05b37fa2e794a738&authtype=sso&custid=ns315887.